-John D Schuetz Researcher Activity Profile

Research Author Detailed Information 

John D Schuetz Publication Rate By Year

John D Schuetz has published 1 paper(s) in 2006, 15 paper(s) in 2007, for a total of 16 research publications in total.

John D Jd Schuetz Author Information

LAST NAME: schuetz

FIRST NAME: John D

INITIALS: jd

AFFILIATION:

Papers

John D Schuetz's Publication Record

1. Multidrug-resistance-associated protein 1 (Mrp1) is probably not required for murine Th cell activation. Year Published: 2006
Institut fuer Medizinische Mikrobiologie und Krankenhaushygiene, University of Marburg, BMFZ, Hans-Meerweinstrasse, 35043 Marburg, Germany. kleemann@med.uni-marburg.de
2. Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide. Year Published: 2007
Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan.
3. cGMP transport by vesicles from human and mouse erythrocytes. Year Published: 2007
Department of Molecular Biology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
4. Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Year Published: 2007
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Japan, and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
5. Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney. Year Published: 2007
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan.
6. The role of transporters in cellular heme and porphyrin homeostasis. Year Published: 2007
Department of Pharmaceutical Sciences, MS 313, St. Jude Children's Research Hospital, 332. N. Lauderdale Avenue, Memphis, TN 38105, United States.
7. Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution. Year Published: 2007
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA.
8. A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression. Year Published: 2007
Division of Clinical Pharmacology, Department of Medicine, The University of Western Ontario, London Health Sciences Centre, University Hospital, London, Ontario, Canada N6A 5A5.
9. Spatiotemporal Coupling of cAMP Transporter to CFTR Chloride Channel Function in the Gut Epithelia. Year Published: 2007
Department of Physiology, The University of Tennessee Health Science Center, 894 Union Avenue, 420 Nash, Memphis, TN 38163, USA.
10. Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one). Year Published: 2007
Pharmacokinetics Laboratory, Mitsubishi Pharma Corporation, Chiba, Japan.
11. Multiple Human Isoforms of Drug Transporters Contribute to the Hepatic and Renal Transport of Olmesartan, a Selective Antagonist of the Angiotensin II AT1-Receptor. Year Published: 2007
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan. sugiyama@mol.f.u-tokyo.ac.jp.
12. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Year Published: 2007
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
13. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Year Published: 2007
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
14. Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia. Year Published: 2007
Department of Physiology, The University of Tennessee Health Science Center, 894 Union Avenue, 420 Nash, Memphis, TN 38163, USA.
15. Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia. Year Published: 2007
Department of Physiology, The University of Tennessee Health Science Center, 894 Union Avenue, 420 Nash, Memphis, TN 38163, USA.
16. Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one). Year Published: 2007
Pharmacokinetics Laboratory, Mitsubishi Pharma Corporation, Chiba, Japan.